Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12126946rdf:typepubmed:Citationlld:pubmed
pubmed-article:12126946lifeskim:mentionsumls-concept:C0035334lld:lifeskim
pubmed-article:12126946lifeskim:mentionsumls-concept:C0752125lld:lifeskim
pubmed-article:12126946lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:12126946pubmed:issue6lld:pubmed
pubmed-article:12126946pubmed:dateCreated2002-7-19lld:pubmed
pubmed-article:12126946pubmed:abstractTextAutosomal dominant spinocerebellar ataxia 7 is associated with retinal degeneration. SCA7, the causative gene, encodes ataxin-7, a ubiquitous 892 amino acid protein of variable sub-cellular localization, and the disease is due to expansion of an unstable CAG repeat in the coding region of the gene. Recent increases in understanding of the mechanisms ofSCA7 -related retinopathy from in vitro and murine model studies prompted us to perform a detailed study of the retinal phenotype of affected members of a family with SCA7 mutation (45-47 CAG repeats). There was a spectrum of severity from mild to severe dysfunction. Early functional abnormalities were at both photoreceptor and post-receptoral levels. When cone and rod photoreceptor dysfunction was present, it was approximately equal. Regional retinal dysfunction was evident: there was more dysfunction centrally than peripherally with least effect in the midperiphery. In vivo cross-sectional retinal images with optical coherence tomography showed an early disease stage of altered foveal lamination (abnormal area of low reflectivity splitting the outer retina-choroidal complex) accompanied in the parafovea by reduced retinal thickness. Later disease stages showed foveal and parafoveal retinal thinning. The phenotype in this family with SCA7 is that of a cone-rod dystrophy. These observations increase interest in a recent hypothesis that ataxin-7 may interfere with the function of CRX (cone-rod homeobox), a transcription factor regulating photoreceptor genes and a cause of a cone-rod dystrophy phenotype in man.lld:pubmed
pubmed-article:12126946pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12126946pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12126946pubmed:languageenglld:pubmed
pubmed-article:12126946pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12126946pubmed:citationSubsetIMlld:pubmed
pubmed-article:12126946pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12126946pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12126946pubmed:statusMEDLINElld:pubmed
pubmed-article:12126946pubmed:monthJunlld:pubmed
pubmed-article:12126946pubmed:issn0014-4835lld:pubmed
pubmed-article:12126946pubmed:authorpubmed-author:JacobsonSamue...lld:pubmed
pubmed-article:12126946pubmed:authorpubmed-author:CideciyanArtu...lld:pubmed
pubmed-article:12126946pubmed:authorpubmed-author:AlemanTomas...lld:pubmed
pubmed-article:12126946pubmed:authorpubmed-author:BriceAlexisAlld:pubmed
pubmed-article:12126946pubmed:authorpubmed-author:VolpeNicholas...lld:pubmed
pubmed-article:12126946pubmed:authorpubmed-author:StevaninGiova...lld:pubmed
pubmed-article:12126946pubmed:issnTypePrintlld:pubmed
pubmed-article:12126946pubmed:volume74lld:pubmed
pubmed-article:12126946pubmed:ownerNLMlld:pubmed
pubmed-article:12126946pubmed:authorsCompleteYlld:pubmed
pubmed-article:12126946pubmed:pagination737-45lld:pubmed
pubmed-article:12126946pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:meshHeadingpubmed-meshheading:12126946...lld:pubmed
pubmed-article:12126946pubmed:year2002lld:pubmed
pubmed-article:12126946pubmed:articleTitleSpinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype.lld:pubmed
pubmed-article:12126946pubmed:affiliationDepartment of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA 19104, USA.lld:pubmed
pubmed-article:12126946pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12126946pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12126946pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12126946lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12126946lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12126946lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12126946lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12126946lld:pubmed